1-7 of 7
Federico Grossi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pegcetacoplan Corrects Hyperbilirubinemia in Both Untreated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and in Patients with PNH Who Previously Received Eculizumab

David J. Araten, Michael Yeh, Mohammed Al-Adhami, Regina Horneff, Federico Grossi
Journal: Blood
Blood (2022) 140 (Supplement 1): 11447–11448.
https://doi.org/10.1182/blood-2022-166623
Published: 2022
Journal Articles

Efficacy and Safety of Pegcetacoplan Treatment in Complement-Inhibitor Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Phase 3 Prince Study

Raymond S Wong, Juan Ramon Navarro, Narcisa Sonia Comia, Yeow Tee Goh, Henry Idrobo, Daolada Kongkabpan, David Gomez-Almaguer, Mohammed Al-Adhami, Temitayo Ajayi, Paulo Alvarenga, Pascal Deschatelets, Cedric Francois, Federico Grossi, Teresita Dumagay
Journal: Blood
Blood (2021) 138 (Supplement 1): 606.
https://doi.org/10.1182/blood-2021-147493
Published: 2021
Journal Articles

The Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Pegcetacoplan Treatment in Healthy Subjects

Federico Grossi, Michael Yeh, Raymond Xu, Pascal Deschatelets
Journal: Blood
Blood (2021) 138 (Supplement 1): 4304.
https://doi.org/10.1182/blood-2021-148069
Published: 2021
Journal Articles

C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials

Raymond S Wong, MBChB, MD, Kalina Ignatova, Humphrey Pullon, Jameela Sathar, Pimjai Niparuck, MD, Tontanai Numbenjapon, Eric Tse, MBBS, PhD FRCP, FRCPath, Surapol Issaragrisil, MD, Eloy Roman, MD, Ismail Amine, Lisa Tan, Carl Di Casoli, Pascal Deschatelets, PhD, Cedric Francois, MD PhD, Federico Grossi, MD, Andrija Bogdanovic
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-134436
Published: 2020
Journal Articles

Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, MBChB, PhD, Jeffrey Szer, MBBS, Ilene C. Weitz, Alexander Röth, MD, Britta Hoechsmann, Jens Panse, MD, Kensuke Usuki, MD PhD, Morag Griffin, MBChB, FRCPath, Jean-Jacques Kiladjian, MD PhD, Carlos M. de Castro, MD, Hisakazu Nishimori, MD PhD, Lisa Tan, Mohamed Hamdani, Pascal Deschatelets, PhD, Cedric Francois, MD PhD, Federico Grossi, MD, Antonio Risitano, Regis Peffault De Latour, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–37.
https://doi.org/10.1182/blood-2020-142174
Published: 2020
Journal Articles

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

Federico Grossi, MD, Merrill Kingman Shum, MD, Morie A. Gertz, MD, Eloy Roman, MD, Pascal Deschatelets, PhD, Mohamed Hamdani, MS, Frank Stout, Cedric G Francois, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3623.
https://doi.org/10.1182/blood-2018-99-119468
Published: 2018
Journal Articles

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Raymond SM Wong, MRCP, FRCP, Humphrey W.H. Pullon, FRACP, FRCPA, Pascal Deschatelets, PhD, Cedric G Francois, MD PhD, Mohamed Hamdani, MS, Surapol Issaragrisil, MD, Patrick Johnson, PhD, Pimjai Niparuck, MD, Tontanai Numbenjapon, MD, Jameela Sathar, MB, MRCP, MRCPath, Lisa Tan, Eric Tse, MBBS, PhD FRCP, FRCPath, Federico Grossi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2314.
https://doi.org/10.1182/blood-2018-99-110827
Published: 2018